Teleflex(US:TFX) ZACKSยท2024-07-25 15:08Company Overview - Teleflex (TFX) is anticipated to report a year-over-year decline in earnings despite higher revenues for the quarter ended June 2024, with a consensus EPS estimate of $3.33, reflecting a -2.4% change from the previous year [1][3][4]. Earnings Expectations - Revenues are projected to be $763.39 million, which is a 2.7% increase compared to the same quarter last year [5]. - The consensus EPS estimate has been revised down by 0.02% over the last 30 days, indicating a reassessment by analysts [5]. Earnings Surprise Prediction - The Most Accurate Estimate for Teleflex is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.66%, suggesting a bearish outlook from analysts [11]. - The stock currently holds a Zacks Rank of 3 (Hold), complicating predictions of an earnings beat [12][13]. Historical Performance - In the last reported quarter, Teleflex exceeded the expected EPS of $3.07 by delivering $3.21, resulting in a surprise of +4.56% [14]. - Over the past four quarters, the company has successfully beaten consensus EPS estimates four times [15]. Industry Comparison - Glaukos (GKOS), another player in the medical instruments industry, is expected to report an EPS of $0.52 for the same quarter, indicating a +5.5% year-over-year change, with revenues expected to reach $88.41 million, up 10% from the previous year [19]. - Glaukos has also seen a downward revision in its consensus EPS estimate by 0.9% over the last 30 days, leading to an Earnings ESP of -0.96% and a Zacks Rank of 3 [20].